Skip to main content
. 2023 Feb 2;18(2):e0281304. doi: 10.1371/journal.pone.0281304

Fig 1. Kaplan-Meier graphs of survival for patients +/- preoperative invasive diagnostic modalities (IDM).

Fig 1

a, intravesical recurrence-free survival; b, intravesical recurrence-free survival in diagnostic subgroups A) voided urine cytology, B) retrograde/antegrade pyelography and/or selective urine cytology, C) ureteropyeloscopy with or without obtaining barbotage cytology, or D) ureteropyeloscopy with tumour biopsy; c, overall survival; d, cancer-specific survival.